EZH2 and head and neck squamous cell carcinoma: The median proportion of EZH2-expressing cells among all malignant cells was 60% [IQR: 30–80] in the general population and 40% [IQR: 3.75–72.5] in the young HNSCC group (p = 0.003; MWU, stat.